New over the counter sleep aids.
Gepotidacin NDA Under Priority Review by FDA for Uncomplicated UTI
Gepotidacin is a first-in-class oral antibiotic with a novel mechanism of action.
Looking to the Future of Independent Pharmacy
Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.
FDA Approves Ceftobiprole Medocaril Sodium for 3 Indications
The FDA approved ceftobiprole medocaril sodium for injection (Zevtera) in April 2024.
Podcast: Pharmacy Financing With First Financial Bank
Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.
FDA Approves First Weekly Subcutaneous Therapy for Hemophilia B
Marstacimab-hncq is the first non-factor and once-weekly treatment available for patients with hemophilia B and promises to reduce the burden of care.
FDA Approves Imuldosa, Biosimilar to Stelara
The approval is supported by results from phase 3 multi-regional clinical trials conducted in patients with plaque psoriasis.